EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 11,360
-210 (-1.82%)
At close: Dec 30, 2025
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 424.3 billion as of December 30, 2025. Its market cap has decreased by -6.42% in one year.
Market Cap
424.30B
Enterprise Value
n/a
Revenue
96.04B
Ranking
n/a
PE Ratio
17.06
Stock Price
11,360.00
Market Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 424.30B, an increase of 245.36%. That is a compound annual growth rate of 14.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 416.60B | -6.15% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1.27T | 93.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 24.33T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.83T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.45T |